𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Two doses of PEG-interferon alfa-2b plus rivabirin in genotype 1 naive patients with chronic hepatitis

✍ Scribed by Marma Buti; Y. Lurie; Francisco Sanchez; Auristela Valdes; Maria Martell; Rafael Esteban; Jaime Guardia


Book ID
118565276
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
109 KB
Volume
36
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Albinterferon alfa-2b dosed every two or
✍ Stefan Zeuzem; Eric M. Yoshida; Yves Benhamou; Stephen Pianko; Vincent G. Bain; πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 528 KB

The efficacy and safety of albinterferon alfa-2b (alb-IFN), a novel recombinant protein consisting of interferon alfa-2b genetically fused to human albumin, was evaluated in a phase 2b, open-label study of patients with genotype 1, chronic hepatitis C. In all, 458 IFN-alfa treatment-naΔ± Β¨ve patients